Skip to main content

Biomanufacturing Program

Manufacturing is fundamental in making the lives of Canadians better and is critical in increasing the overall value of a society. Biomanufacturing is the common operation that connects the many different market sectors of the global biotechnology industry together. This diverse field encompasses the massive production scales of the liquid biofuels industry at one end, to the highly regulated cell therapy and biopharmaceutical industry at the other. 

Biotechnology companies throughout Ontario use living cells to produce enzymes, medicines, and amino acids for diagnostic purposes. This improves lives, creates jobs, and increases the economy. The process of using living cells to create products is called biomanufacturing or bioprocessing. 

Overview

Join us as a student in the ground-breaking first Biomanufacturing Graduate Program in Canada

The Biomanufacturing Graduate Program offered at McMaster University is the first academic program of its kind in Canada in an effort to develop a biomanufacturing ecosystem. The program will train science and technology graduates for high demand leadership roles in this vitally important and rapidly expanding field. The innovative graduate program combines a foundation in biomanufacturing, bioprocessing, and biopharmaceutical theory with experiential learning in many areas, including cGMP manufacturing, regulatory affairs and biocatalysis.

The interdisciplinary curriculum includes academic courses in science and business, along with professional training through case study projects. The program also includes professional skills training in effective oral, electronic, and written communications for futures in both technical and business careers. Biomanufacturing students will develop and run live upstream and downstream bioprocessing projects to completion, using industry-standard equipment in a simulated cGMP environment. These projects will provide an insight in advanced cell therapeutics, novel vaccine design and large-scale production, as well as in the standardization of biomanufacturing processes.

A Growing Industry in Ontario

During the start of the COVID-19 pandemic, Ontario was in a perilous position, which forced them to depend on external sources to supply critical goods, mainly the mRNA vaccines produced by American companies Moderna and Pfizer. The lack of innovation in the Ontario health care sector was also seen.

Although Ontario, along with the rest of Canada, was ill-prepared for dealing with the pandemic, the lack of infrastructure and innovation was not always the case. Canada has an impressive history which can be seen from the hundred year-old discovery of insulin to the scientists who were essential in the development of polio and ebola vaccines. In order to have the ability to manufacture our own vaccines and develop innovative solutions, the biomanufacturing sector needs to be built correctly. A biomanufacturing ecosystem in Ontario requires engagement from academic, investor and industry networks to survive and grow

 

 

Taking Biomanufacturing & Life Sciences to the Next Level

The Taking Biomanufacturing & Life Sciences to the Next Level strategy is a government investment initiative to establish Ontario as a global biomanufacturing and life sciences hub leading in the development and commercialization of innovative health products and services. The main goal of the initiative is to maintain and grow Ontario’s biomanufacturing and life sciences sector by 25% from 66,000 jobs in 2020 to 85,000 jobs in 2030. This will be achieved by a $2.2 billion investment over a 7-year period.

job opportunities

A new $580 million research and manufacturing center is being built at the McMaster Innovation Park, as a part of the government initiative. Home to a subsidiary of CCRM, OmniaBio, the new Contract Development and Manufacturing Organization (CDMO) for Cell and Gene Therapies (CGTs) facility will be used to work on cures for cancer, cardiovascular and Parkinson’s disease, as well as diabetes. The new facility is expected to create 2000 new, full-time jobs by 2026. 

The American-based biotechnology company, Moderna, will be building a manufacturing facility in Canada to produce mRNA vaccines. Expected to be completed by 2024, the new facility will be a vaccine manufacturing hub. 

Master of Engineering in Biomanufacturing

Master of Engineering in Manufacturing Engineering: Biomanufacturing Stream

The Master’s Program in Biomanufacturing at W Booth School of Engineering Practice and Technology is an academic program that trains science and technology graduates for high-demand leadership roles in the vitally important and rapidly expanding biomanufacturing field.

The innovative graduate program combines a foundation in biomanufacturing, bioprocessing, and biopharmaceutical theory with experiential learning in many areas including cGMP manufacturing, regulatory affairs, and biocatalysis. The interdisciplinary curriculum includes academic courses in science and business along with professional training through case study projects. The program also includes professional skills training in effective oral, electronic, and written communications for futures in both technical and business careers. Biomanufacturing students will develop and run live upstream and downstream bioprocessing projects to completion, using industry-standard equipment in a simulated cGMP environment

Highlights of Biomanufacturing

Key Program Information

Students will develop and run live bioprocessing projects from start to finish, using industry-standard equipment in a simulated cGMP (current good manufacturing practices) environment. Offered with a flexible lecture and laboratory schedule, this concentration is designed for early and mid-career professionals who want to enter the biopharmaceutical industry in a range of capacities, including cell-line development, process development, regulatory compliance, quality assurance/quality control, manufacturing and business development.

Full-time students are expected to complete the program in 16 months, but it can be completed between 12 to 24 months. Part-time domestic students are able to complete the program in 32 to 40 months.

  • Application period begins June 15th, 2022
  • Domestic applications close September 30th, 2022
  • International applications close July 15th, 2022
  • 2 mandatory courses
  • 2 to 3 core courses
  • 0 to 1 technical elective courses
  • 2 professional development courses
  • 1 cross-disciplinary elective course
  • 2 project courses

All full-time students must register for the seminar series courses (attendance is mandatory), which are: · SEP 771 / W Booth School of Engineering Practice and Technology Practitioner’s Forum Part I · SEP 771 / W Booth School of Engineering Practice and Technology Practitioner’s Forum Part II

Students pursuing the 8 courses + project pathway are also required to register for two project courses:

  • MANUFACT 701 - MEng Project in Manufacturing Engineering, Part I (3 units)
  • MANUFACT 701 - MEng Project in Manufacturing Engineering, Part II (3 units)

Mandatory Courses:

  • SEP 7XX (code to be determined) - Biomanufacturing (3 units)
  • SEP 767 - Multivariate Statistical Methods for Big Data Analysis and Process Improvement (3 units)

Core Courses:

  • SEP 7XX (code to be determined) - cGMP Upstream Operations (3 units)
  • SEP 7XX (code to be determined) - Fermentation of Recombinant Microorganisms (3 units)
  • SEP 7XX (code to be determined) - Animal Cell Culture Engineering (3 units)
  • SEP 7XX (code to be determined) - cGMP Downstream Operation (3 units)

Technical Elective Courses:

  • SEP 7XX (code to be determined) - Biomedical Engineering (3 units)
  • BIOMED-799 - Independent Study in Biomedical Engineering (3 units)
  • SEP 742 - Membrane based bioseparation (3 units)
  • SEP 6BI3 - Bioinformatics (3 units)
  • SEP 6BS3 - Biotechnology Regulations (3 units)

Professional Development Courses:

  • SEP 6TC3 - Technical Communications (3 units)
  • SEP 725 - Practical Project Management for Today’s Business Environment (3 units)
  • SEP 773 - Leadership for Innovation (3 units)
  • SEP 760 - Design Thinking (3 units)

Cross-Disciplinary Elective Courses:

  • SEP 709 - Emerging Issues, Technology and Public Policy (3 units)
  • SEP 710 - International Governance and Environmental Sustainability (3 units)
  • SEP 6X03 - Livable Cities, The Built and Natural Environment (3 units)
  • SEP 6E03 - Opportunity Identification (3 units)
  • SEP 770 - Total Sustainability Management (3 units)
  • 2 mandatory courses
  • 3 to 5 core courses
  • 0 to 2 technical elective courses
  • 2 professional development courses
  • 1 cross-disciplinary elective course

All full-time students must register for the seminar series courses (attendance is mandatory), which are: · SEP 771 / W Booth School of Engineering Practice and Technology Practitioner’s Forum Part I · SEP 771 / W Booth School of Engineering Practice and Technology Practitioner’s Forum Part II

Students pursuing the 8 courses + project pathway are also required to register for two project courses:

  • MANUFACT 701 - MEng Project in Manufacturing Engineering, Part I (3 units)
  • MANUFACT 701 - MEng Project in Manufacturing Engineering, Part II (3 units)

Mandatory Courses:

  • SEP 7XX (code to be determined) - Biomanufacturing (3 units)
  • SEP 767 - Multivariate Statistical Methods for Big Data Analysis and Process Improvement (3 units)

Core Courses:

  • SEP 7XX (code to be determined) - cGMP Upstream Operations (3 units)
  • SEP 7XX (code to be determined) - Fermentation of Recombinant Microorganisms (3 units)
  • SEP 7XX (code to be determined) - Animal Cell Culture Engineering (3 units)
  • SEP 7XX (code to be determined) - cGMP Downstream Operation (3 units)

Technical Elective Courses:

  • SEP 7XX (code to be determined) - Biomedical Engineering (3 units)
  • BIOMED-799 - Independent Study in Biomedical Engineering (3 units)
  • SEP 742 - Membrane based bioseparation (3 units)
  • SEP 6BI3 - Bioinformatics (3 units)
  • SEP 6BS3 - Biotechnology Regulations (3 units)

Professional Development Courses:

  • SEP 6TC3 - Technical Communications (3 units)
  • SEP 725 - Practical Project Management for Today’s Business Environment (3 units)
  • SEP 773 - Leadership for Innovation (3 units)
  • SEP 760 - Design Thinking (3 units)

Cross-Disciplinary Elective Courses:

  • SEP 709 - Emerging Issues, Technology and Public Policy (3 units)
  • SEP 710 - International Governance and Environmental Sustainability (3 units)
  • SEP 6X03 - Livable Cities, The Built and Natural Environment (3 units)
  • SEP 6E03 - Opportunity Identification (3 units)
  • SEP 770 - Total Sustainability Management (3 units)

Information Session

Student and Industry Testimonials

Kevin Cassidy, Biotech Industry Executive with Pharma, Vaccine and Medical Device Experience

“Traditionally Canada and Ontario have been strong on supporting research and training scientists. Good Canadian ideas and research then moved offshore for product development and manufacturing. This reality hit Governments hard in 2020 when it was realized that Canada did not have the capability to manufacture products to address the COVID pandemic. Today, the table is set for growth of capabilities in advanced product development, scale-up and manufacturing so that Canada has the capability to meet its own needs for biopharmaceutical products…and to supply the world. As a biopharmaceutical company executive, I have long wished for access to new employees that are trained in product development, manufacturing methodologies and applicable regulation. Such training would make new staff members productive in a fraction of the time it takes for a traditionally trained scientist. The McMaster Biomanufacturing Stream program is poised to fill that gap”

Taran Atwal - Prospective Student

Biomanufacturing is at the forefront of modern technology and is revolutionizing everything from cancer treatment to renewable fuels. The Masters of Engineering in Biomanufacturing program is a given for me and future candidates as it's the first program in Canada that will prepare myself and others to lead this revolutionizing sector through learning from industry experts and hands on research opportunities. Biomanufacturing is undeniably doing ground breaking work in facing several global challenges such as global warming, sustainability and climate change. As the future of technology and innovation progresses, Biomanufacturing will undoubtedly play a vital role in the enhancement of several processes and applications.